$NXGL

Levy Adam R. sold $2K of NXGL

Levy Adam R. (Chief Executive Officer) sold 3,000 shares of NEXGEL, INC. (NXGL) at $0.61 on 2026-06-11.

Original reporting
SEC EDGAR · Levy Adam R.
Published Jun 15, 2026, 9:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 9:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NXGL
Neutral
high confidence
Mentioned
$NXGL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NXGLNeutralLow
01

Why it matters

The newest concrete fact is the CEO’s open-market sale of 3,000 shares at $0.6136/share, totaling $1,840.80, with holdings after sale of 333,692 shares.

02

Market read

Traders may monitor for follow-on insider activity or correlate with any concurrent company catalysts, but this filing alone is unlikely to drive a major repricing.

03

What to watch

The text does not state whether proceeds were for taxes, diversification, or other obligations; absence of a 10b5-1 plan could increase scrutiny but still lacks context.

Relevance 3/10Novelty 6/10Timing: Filed 2026-06-15; transaction dated 2026-06-11

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for NEXGEL, INC. (NXGL).

Company-level read

Ticker impact

$NXGLNeutralHigh confidence
Context

SEC Form 4 shows CEO Levy Adam R. sold 3,000 NXGL shares in an open-market transaction on 2026-06-11.

Expected impact

Low likelihood of a sustained price move; any impact would be short-lived unless paired with other new catalysts.

Evidence & confidence

The filing is a disclosed insider sale (not a buy), with no 10b5-1 plan and no accompanying operational/regulatory/financial catalyst in the text.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be pre-planned for liquidity/tax and may not reflect bearish fundamentals, especially when the company-specific news is absent.

Key entities

  • NEXGEL, INC.

    Subject of the Form 4 insider transaction disclosure (NXGL).

  • Levy Adam R.

    CEO and officer/director who sold shares via open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NXGLLow

NEXGEL, INC. (NXGL): Results of Operations and Financial Condition

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content